Sam WhitingVentiRx Pharmaceuticals关注立即认领分享关注立即认领分享基本信息浏览量:0职业迁徙个人简介暂无内容研究兴趣论文共 2 篇作者统计合作学者相似作者按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选时间引用量主题期刊级别合作者合作机构Comparison of immune modulation by TLR8 agonist vtx-2337 (motolimod) in cancer patients and healthy volunteersGreg Dietsch,Sam Whiting,Donald Northfelt,Ramesh Ramanathan,Peter Cohen,Kristi Manjarrez, Mona Newkirk, James Kyle Bryan,Robert HershbergJournal for ImmunoTherapy of Cancer(2014)引用0浏览0引用00Active8: a randomized, double-blind, placebo-controlled study of chemotherapy plus cetuximab in combination with TLR8 agonist VTX-2337 in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN)Robert L Ferris,Ezra Cohen, Kelly Gash,Sam Whiting,Kristi Manjarrez,Greg Dietsch,Robert Hershberg, James Kyle BryanJournal for ImmunoTherapy of Cancer(2014)引用0浏览0引用00作者统计合作学者合作机构D-Core合作者学生导师暂无相似学者,你可以通过学者研究领域进行搜索筛选数据免责声明页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn